Detalles de la búsqueda
1.
Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy.
PLoS One
; 16(6): e0252274, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34086708
2.
Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs-First real world data from Austria.
PLoS One
; 15(3): e0229239, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32155165
3.
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease.
Eur J Gastroenterol Hepatol
; 30(3): 291-295, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29120906
Resultados
1 -
3
de 3
1
Próxima >
>>